Abstract
The ability of the intervertebral disc to resist compression is dependent on its high proteoglycan concentration. The disc proteoglycans are classified as aggregating or non-aggregating depending on their ability to interact with hyaluronan. The majority of the aggregating proteoglycans are derived from aggrecan, though their glycosaminoglycan substitution pattern has not been determined. In contrast, the origin of the non-aggregating proteoglycans is unclear, though it has been postulated that they are derived from aggrecan by proteolysis. The present work demonstrates that keratan sulfate (KS) in the glycosaminoglycan-binding region of disc aggrecan is confined to the KS-rich domain of the core protein and is not present in association with chondroitin sulfate (CS) in the CS1 and CS2 domains. It also shows that the non-aggregating disc proteoglycans are derived from aggrecan, with the large molecules possessing both the KS-rich and CS1 domains and the smaller molecules being generated from either the KS-rich or CS2 domain. The origin and spectrum of disc proteoglycan heterogeneity is the same in both the annulus fibrosus and nucleus pulposus.
Similar content being viewed by others
References
Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, Aebi M, Alini M (1996) The human lumbar intervertebral disc—evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest 98:996–1003
Bayliss MT, Roughley PJ (1985) The properties of proteoglycan prepared from human articular cartilage by using associative caesium chloride gradients of high and low starting densities. Biochem J 232:111–117
Benjamin M, Ralphs JR (2004) Biology of fibrocartilage cells. Int Rev Cytol 233:1–45
Björnsson S (1993) Size-dependent separation of proteoglycans by electrophoresis in gels of pure agarose. Anal Biochem 210:292–298
Bushell GR, Ghosh P, Taylor TFK, Akeson WH (1977) Proteoglycan chemistry of intervertebral disks. Clin Orthop 129:115–123
Cassinelli EH, Hall RA, Kang JD (2001) Biochemistry of intervertebral disc degeneration and the potential for gene therapy applications. Spine J 1:205–214
Doege KJ, Sasaki M, Kimura T, Yamada Y (1991) Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem 266:894–902
Goupille P, Jayson MIV, Valat JP, Freemont AJ (1998) Matrix metalloproteinases: the clue to intervertebral disc degeneration? Spine 23:1612–1626
Hascall VC (1988) Proteoglycans: the chondroitin sulfate/keratan sulfate proteoglycan of cartilage. ISI Atlas Sci Biochem 1:189–198
Hughes CE, Caterson B, White RJ, Roughley PJ, Mort JS (1992) Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin. J Biol Chem 267:16011–16014
Jahnke MR, McDevitt CA (1988) Proteoglycans of the human intervertebral disc. Electrophoretic heterogeneity of the aggregating proteoglycans of the nucleus pulposus. Biochem J 251:347–356
Karlsson M, Edfors-Lilja I, Bjornsson S (2000) Binding and detection of glycosaminoglycans immobilized on membranes treated with cationic detergents. Anal Biochem 286:51–58
McDevitt CA (1988) Proteoglycans of the intervertebral disc. In: Ghosh P (ed) Biology of the intervertebral disc. CRC Press, Boca Raton, pp 151–170
Mehmet H, Scudder P, Tang PW, Hounsell EF, Caterson B, Feizi T (1986) The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series. Eur J Biochem 157:385–391
Nilsson B, De Luca S, Lohmander S, Hascall VC (1982) Structures of N-linked and O-linked oligosaccharides on proteoglycan monomer isolated from the Swarm rat chondrosarcoma. J Biol Chem 257:10920–10927
Oegema TR (1993) Biochemistry of the intervertebral disc. Clin Sports Med 12:419–439
Poole AR, Webber C, Reiner A, Roughley PJ (1989) Studies of a monoclonal antibody to skeletal keratan sulphate. Importance of antibody valency. Biochem J 260:849–856
Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM (2000) Matrix metalloproteinases and aggrecanase—their role in disorders of the human intervertebral disc. Spine 25:3005–3013
Roberts S, Urban JPG (2003) Degeneration of intervertebral disc. Arthritis Res Ther 5:120–130
Roughley PJ (1978) A comparative study of the glycosaminoglycan-peptides obtained after degradation of cartilage proteoglycan by different proteinases, and their use in the characterization of different proteoglycans. Connect Tissue Res 6:145–153
Roughley PJ (2004) Biology of intervertebral disc aging and degeneration—involvement of the extracellular matrix. Spine 29:2691–2699
Roughley PJ, Alini M, Antoniou J (2002) The role of proteoglycans in aging, degeneration and repair of the intervertebral disc. Biochem Soc Trans 30:869–874
Roughley PJ, Mort JS (1986) Ageing and the aggregating proteoglycans of human articular cartilage. Clin Sci 71:337–344
Roughley PJ, White RJ (1980) Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. J Biol Chem 255:217–224
Roughley PJ, White RJ, Cs-Szabó G, Mort JS (1996) Changes with age in the structure of fibromodulin in human articular cartilage. Osteoarthr Cartil 4:153–161
Roughley PJ, White RJ, Magny M-C, Liu J, Pearce RH, Mort JS (1993) Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J 295:421–426
Santer V, White RJ, Roughley PJ (1982) O-linked oligosaccharides of human articular cartilage proteoglycans. Biochim Biophys Acta 716:277–282
Scott JE, Bosworth TR, Cribb AM, Taylor JR (1994) The chemical morphology of age-related changes in human intervertebral disc glycosaminoglycans from cervical, thoracic and lumbar nucleus pulposus and annulus fibrosus. J Anat 184:73–82
Sztrolovics R, Alini M, Mort JS, Roughley PJ (1999) Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine 24:1765–1771
Sztrolovics R, Grover J, CS-Szabo G, Shi SL, Zhang YP, Mort JS, Roughley PJ (2002) The characterization of versican and its message in human articular cartilage and intervertebral disc. J Orthop Res 20:257–266
Tortorella MD, Liu RQ, Burn T, Newton RC, Arner E (2002) Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 21:499–511
Tortorella MD, Pratta M, Liu RQ, Austin J, Ross OH, Abbaszade I, Burn T, Arner E (2000) Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem 275:18566–18573
Urban JPG, Roberts S, Ralphs JR (2000) The nucleus of the intervertebral disc from development to degeneration. Am Zool 40:53–61
Watanabe H, Yamada Y, Kimata K (1998) Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function (Tokyo). J Biochem (Tokyo) 124:687–693
Acknowledgement
This work was supported by research funding from the Shriners of North America.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roughley, P.J., Melching, L.I., Heathfield, T.F. et al. The structure and degradation of aggrecan in human intervertebral disc. Eur Spine J 15 (Suppl 3), 326–332 (2006). https://doi.org/10.1007/s00586-006-0127-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-006-0127-7